PPCB
Propanc Biopharma, Inc. Common Stock
NASDAQ: PPCB · HEALTHCARE · BIOTECHNOLOGY
$0.10
-0.29% today
Updated 2026-05-04
Market cap
$2.26M
P/E ratio
0.00
P/S ratio
—
EPS (TTM)
$52.11
Dividend yield
—
52W range
$0 – $11
Volume
3.9M
WallStSmart proprietary scores
26
out of 100
Grade: F
Strong Sell
Investment rating
4.3
Growth
C5.0
Quality
C+3.0
Profitability
D5.0
Valuation
C+—/9
Piotroski F-Score
—
—
Altman Z-Score
—
—
Industry rank
—
View all highly rated stocks (75+) →198 stocks currently score above 75
Price targets
Analyst target
$1.52
+1375.73%
12-Month target
$354.35
+343929.13%
Intrinsic (DCF)
—
Margin of safety
—
Price chart
X-Ray snapshot
Strengths
Insufficient data
Risks
- Thin margins at 0.00%
- Negative free cash flow $-1.00M
Key financials
Revenue Net Income Free Cash Flow
| Metric | 2022 | 2023 | 2024 | 2025 | TTM |
|---|---|---|---|---|---|
| Revenue | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 |
| Net income | $-2.66M | $-2.66M | $-1.82M | $-58.92M | $-3.09M |
| EPS | — | — | — | — | $52.11 |
| Free cash flow | $-1.44M | $-1.11M | $-935120.00 | $-405168.00 | $-1.00M |
| Profit margin | — | — | — | — | — |
Peer comparison
Smart narrative
Propanc Biopharma, Inc. Common Stock trades at $0.10. Our Smart Value Score of 26/100 indicates the stock is weak.
Frequently asked questions
What is Propanc Biopharma, Inc. Common Stock's stock price?
Propanc Biopharma, Inc. Common Stock (PPCB) trades at $0.10.
Is Propanc Biopharma, Inc. Common Stock overvalued?
Smart Value Score 26/100 (Grade F, Strong Sell).
What is the price target of Propanc Biopharma, Inc. Common Stock (PPCB)?
The analyst target price is $1.52, representing +1375.7% upside from the current price of $0.10.
Company info
SectorHEALTHCARE
IndustryBIOTECHNOLOGY
CountryUSA
ExchangeNASDAQ
CurrencyUSD
Quick metrics
P/S ratio—
ROE-1,812.00%
Beta3.53
50D MA$0.13
200D MA$1.59
Shares out0.02B
Float0.01B
Short ratio—
Avg volume3.9M
Performance
1 week—
1 month—
3 months—
YTD—
1 year—
3 years—
5 years—